ARBs and MI risk refuted in meta-analysis

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1350, 2011-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HBOC meta-analysis refuted by Biopure

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cardiovascular Outcomes in High-Risk Patients without Heart Failure Treated with ARBs: A Systematic Review and Meta-Analysis

By Khalaf Mohamad M. Al

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 29-43

Adis International

Access to resources Recommend Favorite

Psychotropic Medications and the Risk of Fracture: A Meta-Analysis

By Takkouche Bahi

Drug Safety, Vol. 30, Iss. 2, 2007-01 ,pp. : 171-184

Adis International

Access to resources Recommend Favorite

Network Meta-Analysis with Competing Risk Outcomes

By Ades A. E. Mavranezouli Ifigeneia Dias Sofia Welton Nicky J. Whittington Craig Kendall Tim

Value in Health, Vol. 13, Iss. 8, 2010-12 ,pp. : 976-983

Blackwell Publishing

Access to resources Recommend Favorite

XPD Polymorphisms, Cigarette Smoking, and Bladder Cancer Risk: A Meta-Analysis

By Wang Meilin Gu Dongying Zhang Zhizhong Zhou Jianwei Zhang Zhengdong

Journal of Toxicology and Environmental Health, Vol. 72, Iss. 11-12, 2009-01 ,pp. : 698-705

Taylor & Francis Ltd

Access to resources Recommend Favorite